LNTH Q4 2017 Earnings — Lantheus Holdings, Inc. Revenue & Financial Results | Market Cap Arena

LNTHLantheus Holdings, Inc.

$5B

Q4 2017 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$81M+9.3% YoY

Gross Profit

$38M46.7% margin

Operating Income

$9M11.3% margin

Net Income

$97M119.6% margin

EPS (Diluted)

$2.47

QoQ Revenue Growth

+1.6%

Cash Flow

Operating Cash Flow

$13M

Free Cash Flow

$7M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$384M

Total Liabilities

$361M

Stockholders' Equity

$23M

Cash & Equivalents

$76M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$81M	$74M	+9.3%
Gross Profit	$38M	$35M	+9.4%
Operating Income	$9M	$12M	-24.2%
Net Income	$97M	$5M	+1894.8%

Revenue Segments

US Segment

$71M88%

International Segment

$10M12%